Rhinovirus infections: Induction and modulation of airways inflammation in asthma

Clinical and Experimental Allergy, Supplement

Volumn 29, Issue 2, 1999, Pages 65-73

  Grunberg K ^b   Sterk, P J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Airway hyperresponsiveness; Asthma exacerbation; Common cold; Immune responses; Respiratory virus infection

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE;

ALLERGIC ASTHMA; ANIMAL CELL; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; COMMON COLD; CONFERENCE PAPER; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LOWER RESPIRATORY TRACT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHINOVIRUS; T LYMPHOCYTE;

ADULT; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; COMMON COLD; CYTOKINES; EOSINOPHILS; EPITHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NITRIC OXIDE; RHINOVIRUS;

EID: 0033049124     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (112)

1. Welliver RC. RSV and chronic asthma. Lancet 1995; 34:789-90.
2. Macek V, Sorli J, Kopriva S, Marin J. Persistent adenoviral infection and chronic airway obstruction in children. Am J Respir Crit Care Med 1994; 150:7-10.
3. Martinez FD. Role of viral infections in the inception of asthma and allergies during childhood: could they be protective? Thorax 1994; 49:1189-91.
4. Shaheen SO, Aaby P, Hall AJ et al. Measles and atopy in Guinea-Bissau. Lancet 1997; 347:1792-6.
5. Corne JM, Holgate ST. Mechanisms of virus induced exacerbations of asthma. Thorax 1997; 52:380-9.
6. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998; 157:1708-20.
7. Matsuse T, Hayashi S, Kuwano K et al. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146:177-84.
8. Seemungal T, Donaldson GC, Breuer J et al. Rhinoviruses are associated with exacerbations in COPD. Am J Respir Crit Care Med 1998; 157:A173.
9. Neuzil KM, Graham BS. Cytokine release and innate immunity in respiratory viral infection. Semin Virol 1996; 7:255-64.
10. Schwarze J, Hamelmann E, Bradley KL, Takeda K, Gelfand EW. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 1997; 99:226-33.
11. Roman M, Calhoun WJ, Hinton KL et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997; 156:190-5.
12. Gern JE, Busse WW. The effects of rhinovirus infections on allergic airway responses. Am J Respir Crit Care Med 1995; 152:540-3.
13. Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy 1992; 22:325-36.
14. Beasley R, Coleman ED, Hermon Y et al. Viral respiratory tract infection and exacerbations of asthma in adult patients. Thorax 1988; 43:679-83.
15. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307:982-6.
16. McIntosh K, Ellis EF, Hoffman LS et al. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr 1973; 82:578-90.
17. Minor TE, Dick EC, DeMeo AN et al. Viruses as precipitants of asthmatic attacks in children. JAMA 1974; 227:292-8.
18. Horn MEC, Brain EA, Gregg I. Respiratory virus infection and wheezy bronchitis in childhood. Thorax 1979; 34:23-8.
19. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310:1225-9.
20. Minor TE, Baker JW, Dick EC et al. Greater frequency of viral respiratory infections in asthmatic children as compared with their nonasthmatic siblings. J Pediatr 1974; 85:472-7.
21. Gwaltney JM Jr, Hendley O, Hayden FG et al. Updated recommendations for safety-testing of viral inocula used in volunteer experiments on rhinovirus colds. Prog Med Virol 1992; 39:256-63.
22. Halperin SA, Eggleston PA, Beasley P et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985; 132:976-80.
23. Bardin PG, Fraenkel DJ, Sanderson G et al. Amplified rhinovirus colds in atopic subjects. Clin Exp Allergy 1994; 24:457-64.
24. Lemanske RF Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989; 83:1-10.
25. Cheung D, Dick EC, Timmers MC et al. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med 1995; 152:1490-6.
26. Fraenkel DJ, Bardin PG, Sanderson G et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995; 151:879-86.
27. 1 in asthmatics. Eur Respir J 1997; 10:9s.
28. Grünberg K, Timmers MC, Smits HH et al. Effects of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin Exp Allergy 1997; 27:36-45.
29. Grünberg K, Kuijpers EAP, De Klerk EPA et al. Effects of experimental rhinovirus 16 (RV16) infection on airway hyperresponsiveness to bradykinin in asthmatic subjects in vivo. Am J Respir Crit Care Med 1997; 155:833-8.
30. Grünberg K, Smits HH, Timmers MC et al. Experimental rhinovirus 16 infection: effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997; 156:609-16.
31. Halperin SA, Eggleston PA, Hendley JO et al. Puthogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. Am Rev Respir Dis 1983; 128:806-10.
32. Calhoun WJ, Swenson CA, Dick EC et al. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1991; 144:1267-73.
33. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994; 94:2200-8.
34. Gern JE, Calhoun WJ, Swenson CA, Shen G, Busse WW. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 1997; 155:1872-6.
35. Skoner DP, Doyle WJ, Seroky J, Van Deusen MA, Fireman P. Lower airway responses to rhinovirus 39 in healthy allergic and nonallergic subjects. Eur Respir J 1996; 9:1402-6.
36. Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest 1995; 96:2393-403.
37. Hogg JC. Pathology of asthma. J Allergy Clin Immunol 1993; 92:1-5.
38. Redington AE, Howarth PH. Airway remodelling in asthma. Thorax 1997; 52:310-2.
39. Robinson PJ, Hegele RG, Schellenherg RR. Allergic sensitization increases airway reactivity in guinea pigs with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 1997; 100:492-8.
40. Folkerts G, Verheyen KCP, Geuens GMA, Folkerts HF, Nijkamp FP. Virus-induced changes in airway responsiveness, morphology, and histamine levels in guinea pigs. Am Rev Respir Dis 1993; 147:1569-57.
41. Huftel MA, Swensen CA, Borcherding WR et al. The effect of T-cell depletion on enhanced basophil histamine release after in vitro incubation with live influenza A virus. Am J Respir Cell Mol Biol 1992; 7:434-40.
42. Folkerts G, Verheyen A, Janssen M, Nijkamp FP. Virus-induced airway hyperresponsiveness in the guinea pig can be transferred by bronchoalveolar cells. J Allergy Clin Immunol 1992; 90:364-72.
43. van Oosterhout AJM, van Ark I, Folkers G et al. Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. Am J Respir Crit Care Med 1995; 151:177-83.
44. Jacoby DB. Virus-induced bronchial hyperreactivity. In: Raeburn D, Giembycz MA (eds). Airways smooth muscle modelling the asthmatic response in vivo. Basel: Birkhäuser-Verlag 1996:121-45.
45. Dusser DJ, Jacoby DB, Djokic TD et al. Virus induces airway hyperresponsiveness to tachykinins: role of neutral endopeptidase. J Appl Physiol 1989; 67:1504-11.
46. Kahn RM, Okaniami OA, Jacoby DB, Fryer AD. Viral infection induces dependence of neuronal M2 muscarinic receptors on cyclooxygenase in guinea pig lung. J Clin Invest 1996; 98:299-307.
47. Folkerts G, van der Linde HJ, Nijkamp FP. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J Clin Invest 1995; 95:26-30.
48. De Gouw HWFM, van Sterkenburg MAJA, van Wetering S et al. Expression of inducible nitric oxide synthase (iNOS) mRNA in human primary bronchial epithelial cells in vitro: effects of cytokines and rhinovirus-16. Am J Respir Crit Car Med 1998; 157:A24.
49. Sanders SP, Siekierski ES, Porter JD, Richards SM, Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 1998; 72:934-42.
50. De Gouw HWFM, Grünberg K, Schot R et al. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 1998; 11:126-32.
51. Johnston SL, Mastronarde JG, Monick MM et al. Rhinoviruses induce prolonged interleukin-8 release, increases mRNA and promotor activation in pulmonary epithelial and peripheral blood mononuclear cells. Am J Respir Crit Care Med 1995; 151:A773.
52. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokinc release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995; 96:549-57.
53. Zhu Z, Tang W, Ray A et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor κB-dependent transcriptional activation. J Clin Invest 1996; 97:421-30.
54. Cazemier II, Sterkenhurg MAJA, Manesse-Lazeroms SPG et al. Rhinovirus 16 (RV16) stimulates production and release of the chemokines IL-8 and RANTES in subcultures of human primary bronchial epithelial cells. Eur Respir J 1996; 9:424s.
55. Terajima M, Yamaya M, Sekizawa K et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. Am J Physiol 1997; 273:L749-59.
56. Papi A, Wilson SJ, Johnston SL. Rhinoviruses increase production of adhesion molecules (CAM) and NF-κB. Am J Respir Crit Care Med 1996; 153:A866.
57. Zhu Z, Tang W, Gwaltney JM, Wu Y, Elias JA. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-κB. Am J Physiol 1997; 273:L814-24.
58. Johnston SL, Papi A, Bates PhJ et al. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 1998; 160:6172-81.
59. Cazemier H, Grünberg K, de Kluijver J et al. Rhinovirus (RV)-16 induced nasal inflammation is characterized by an influx of neutrophils and increased chemokine expression in mild asthmatics. Eur Respir J 1997; 10:463s.
60. Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990; 161:120-3.
61. Igarashi Y, Skoner DP, Doyle WJ et al. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol 1993; 92:722-31.
62. Proud D, Gwaltney JM Jr, Hendley JO et al. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 1994; 169: 1007-13.
63. Linden M, Greiff L, Andersson M et al. Nasal cytokines in common cold and allergic rhinitis. Clin Exp Allergy 1995; 25:166-72.
64. Roseler S, Holtappels G, Wagenmann M, Bachert C. Elevated levels of interleukins IL-1 beta, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol Suppl 1995; 1:S61-3.
65. Teran LM, Johnston SL, Holgate ST. Immunoreactive RANTES and MIP-1α are increased in the nasal aspirates of children with virus-associated asthma. Am J Respir Crit Care Med 1995; 151:A385.
66. Einarsson O, Geba GP, Zhu Z, Landry M, Elias JA. Interleukin-II: Stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest 1996; 97:915-24.
67. Teran LM, Johnston SL, Schroder J-M, Church MK, Holgate ST. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997; 155:1362-6.
68. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95: 843-52.
69. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - cxc and cc chemokines. Adv Immunol 1994; 55:97-179.
70. Winther B, Farr B, Turner RB et al. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol (Suppl)(Stockholm) 1984; 413:19-24.
71. Levandowski RA, Weaver CW, Jackson GG, Nasal-secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection. J Med Virol 1988; 25:423-32.
72. Naclerio RM, Proud D, Lichtenstein LM et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 1988; 157:133-42.
73. Fraenkel DJ, Bardin PG, Sanderson G et al. Immunohistochemical analysis of nasal biopsies during rhinovirus experimental colds. Am J Respir Crit Care Med 1994; 150:1130-6.
74. Levandowski RA, Ou DW, Jackson GG. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis 1986; 153:743-8.
75. Canonica GW, Ciprandi G, Pesce GP et al. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 1995; 107:99-102.
76. Winther B, Greve JM, Gwaltney JMJ et al. Surface expression of intercellular adhesion molecule 1 on epithelial cells in the human adenoid. J Infect Dis 1997; 176:523-5.
77. Bloemen PGM, Hendricks PAJ, Nijkamp FP. Cell adhesion and asthma. Clin Exp Allergy 1997; 27:128-41.
78. Handzel ZT, Busse WW, Sedgwick JB et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 1998; 160:1279-84.
79. Greve JM, Davis G, Meyer AM et al. The major human rhinovirus receptor is ICAM-1. Cell 1989; 56:839-47.
80. Staunton DE, Merluzzi VJ, Rothlein R et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989; 56:849-53.
81. Sharon RF, Grünberg K, Van Krieken JHJM et al. Experimental rhinovirus (RV)-16 infection enhances ICAM-1 expression in bronchial mucosal biopsies of mildly asthmatic subjects, regardless of inhaled steroid treatment. Am J Respir Crit Care Med 1998; 157:A22.
82. Grunert HP, Wolf KU, Langner KD et al. Internalization of human rhinovirus 14 into HeLa and ICAM-1-transfected BHK cells. Med Microbiol Immunol 1997; 186:1-9.
83. Piela-Smith TH, Aneiro L, Korn JH. Binding of human rhinovirus and T cells to intercellular adhesion molecule-1 on human fibroblasts. Discordance between effects of IL-1 and IFN-gamma. J Immunol 1991; 147:1831-6.
84. Piela-Smith TH, Broketa G, Hand A, Korn JH. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J Immunol 1992; 148:1375-81.
85. Wimalasundera SS, Katz DR, Chain BM. Characterization of the T cell response to human rhinovirus in children: Implications tor understanding the immunopathology of the common cold. J Infect Dis 1997; 176:755-9.
86. Gern JE, Joseph B, Galagan DM, Borcherding WR, Dick EC. Rhinovirus inhibits antigen-specific T cell proliferation through an intercellular adhesion molecule-1 dependant mechanism. J Infect Dis 1996; 174:1143-50.
87. Staunton DE, Dustin ML, Erickson HP, Springer TA. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990; 61:243-54.
88. Hsia J, Goldstein AL, Simon GL, Sztein M, Hayden FG. Peripheral blood mononuclear cell interleukin-2 and interferon-gamma production, cytotoxicity, and antigen-stimulated blastogenesis during experimental rhinovirus infection. J Infect Dis 1990; 162:591-7.
89. Levandowski RA, Hurohov DW. Rhinovirus induces natural killer-like cytotoxic cells and interferon alpha in mononuclear leukocytes. J Med Virol 1991; 35:116-20.
90. Gern JE, Dick EC, Ming Lee W et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 1996; 156:621-7.
91. Gern JE, Vrtis RF, Kelly EAB, Dick EC, Busse WW, Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol 1996; 157:1605-12.
92. Levandowski RA, Pachucki CT, Rubenis M. Specific mononuclear cell response to rhinovirus. J Infect Dis 1983; 148:1125.
93. Skoner DP, Whiteside TL, Wilson JW et al. Effect of rhinovirus 39 infection on cellular immune parameters in allergic and nonallergic subjects. J Allergy Clin Immunol 1993; 92:732-43.
94. Hastings GZ, Rowlands DJ, Francis MJ. Proliferative responses of T cells primed against human rhinovirus to other rhinovirus serotypes. J Gen Virol 1991; 72:2947-52.
95. Gern JE, Dick EC, Kelly EAB, Vrtis RF, Klein B. Rhinovirus-specific T cells recognize both shared and serotype-restrieted viral epitopes. J Infect Dis 1997; 175:1108-14.
96. Winther B, Gwaltney JM Jr, Mygind N, Turner RB, Hendley JO. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 1986; 256:1763-7.
97. Johnston SL, Sanderson G, Pattemore PK et al. Use of polymerase chain reaction for diagnosis of picomavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol 1993; 31:111-7.
98. Horn MEC, Reed SE, Taylor PM. Role of viruses and bacteria in acute wheezy bronchitis in childhood: a study of sputum. Arch Dis Child 1979; 54:587-92.
99. Schmidt HJ, Fink RJ. Rhinovirus as a lower respiratory tract pathogen in infants. Pediatr Infect Dis J 1991; 10:700-2.
100. Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997; 155:1159-61.
101. Ciprandi G, Pronzato C, Ricca V et al. Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Am J Respir Crit Care Med 1994; 150:1653-9.
102. Alper CM, Doyle WJ, Skoner DP et al. Prechallenge antibodies: moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39. Laryngoscope 1996; 106:1298-305.
103. Bruce C, Chadwick P, al-Nakib W. Detection of rhinovirus RNA in nasal epithelial cells by in situ hybridization. J Virol Meth 1990; 30:115-25.
104. Arruda E, Boyle TR, Winther B et al. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis 1995; 171:1329-33.
105. Bardin PG, Johnston SL, Sanderson G et al. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. Am J Respir Cell Mol Biol 1994; 10:207-13.
106. Bates PJ, Bardin PG, Fraenkel DJ et al. Localisation of rhinovirus in the bronchial epithelium of experimentally-infected human volunteers. Am J Respir Crit Care Med 1998; 157:A25.
107. Montefort S, Gratziou C, Goulding D et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothclial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994; 93:1411-21.
108. Sterk PJ. Repeated low dose allergen exposure: a new investigational model of asthma as a persistent disease? Eur Respir J 1998; 11:798-800.
109. Arshad S, Hamilton RB, Adkinson NF, Jr. Repeated aerosol exposure to small doses of allergen. A model of chronic allergic asthma. Am J Respir Crit Care Med 1998; 157:1900-6.
110. Johnston SL, Pattemore PK, Sandeson G et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996; 154:654-60.
111. Doull IJM, Lampe FC, Smith S et al. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: a randomised double blind placebo controlled trial. BMJ 1997; 315:858-62.
112. Svedmyr J, Nyberg E, Asbrink-Nilsson E, Hedlin G. Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infection. Acta Paediatr 1995; 84:884-8.